We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current CARA market cap is 72.99M. The company's latest EPS is USD -15.4948 and P/E is -1.03.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 3M | 2.14M | 991k | 2.56M | 1.46M |
| Operating Income | -32.61M | -29.67M | -17.31M | -5.99M | -5.42M |
| Net Income | -32.34M | -30.7M | -20.02M | -12.48M | -7.68M |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 135.08M | 23.03M | 41.87M | 20.97M | 7.14M |
| Operating Income | 5.39M | -89.08M | -87.54M | -121.5M | -58.38M |
| Net Income | 8.41M | -88.44M | -85.47M | -118.51M | -70.87M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 125.84M | 90.1M | 72.5M | 51.33M | 43.83M |
| Total Liabilities | 68.76M | 60.3M | 60.9M | 50.62M | 48.42M |
| Total Equity | 57.09M | 29.8M | 11.6M | 707k | -4.59M |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 271.16M | 247.06M | 182.24M | 125.84M | 43.83M |
| Total Liabilities | 22.16M | 19.53M | 23.46M | 68.76M | 48.42M |
| Total Equity | 249M | 227.52M | 158.78M | 57.09M | -4.59M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -92.08M | -30.45M | -42.89M | -56.87M | -60.92M |
| Investing | 43.46M | 25.95M | 41.24M | 43.74M | 48.74M |
| Financing | 38.15M | -836k | -1.3M | -1.99M | -3.6M |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -5.49M | -60.09M | -78.73M | -92.08M | -60.92M |
| Investing | -20.28M | -4.75M | 128.71M | 43.46M | 48.74M |
| Financing | 39.14M | 46.61M | 311k | 38.15M | -3.6M |
| Market Cap | 72.99M |
| Price to Earnings Ratio | -1.03 |
| Price to Sales Ratio | 10.23 |
| Price to Cash Ratio | 1.93 |
| Price to Book Ratio | -15.89 |
| Dividend Yield | - |
| Shares Outstanding | 4.57M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 28.56k |
| 52 Week Change | 101.52% |
| 52 Week High | 15.96 |
| 52 Week Low | 2.7084 |
| Spread (Intraday) | 1 (15.9%) |
| Company Name | Cara Therapeutics Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.tvarditherapeutics.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
